BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• 

  Sickle cell disease

  Vertex, Beam Report SCD Cell and Gene Therapies Advances at ASH 2024

  Vertex unveiled long-term durability data for Casgevy, while Beam presented Phase I/II findings for its investigational base editor BEAM-101, building up to a BLA by late 2026.

  December 9, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Mergers & acquisitions

  Novo, Catalent $16.5B Deal Wins EU Blessing as US Antitrust Scrutiny Mounts

  In the U.S., the chorus of opposition against the proposed buyout continues to grow and now includes the CEOs of Roche and Lilly, a broad coalition of unions and consumer groups and at least one senator.

  December 9, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Obesity

  BioAge Crashes After Axing Phase II Obesity Study

  The discontinuation of STRIDES is a rare stumble for the next-generation obesity field and comes just weeks after Amgen announced underwhelming mid-stage data for MariTide.

  December 9, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Cogent Biosciences Announces Updated Clinical Results from SUMMIT, Showcasing Powerful Symptomatic Improvement in NonAdvanced Systemic Mastocytosis Patients

  December 9, 2024

   · 

  8 min read
• Press Releases

  InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR)

  December 9, 2024

   · 

  6 min read
• Press Releases

  FDA Grants Breakthrough Therapy Designation to Seres Therapeutics’ SER-155 for Reduction of Bloodstream Infections in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)

  December 9, 2024

   · 

  9 min read
• Press Releases

  Solu Therapeutics Presents Positive Preclinical Data on STX-0712 for Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia at ASH Annual Meeting

  December 9, 2024

   · 

  3 min read
• Press Releases

  Seismic Therapeutic Presents New Preclinical Efficacy Data for S-1117 in Prophylactic and Therapeutic Animal Models of Immune Thrombocytopenia (ITP) at 66th ASH Annual Meeting

  December 9, 2024

   · 

  3 min read
• Press Releases

  Datopotamab deruxtecan granted breakthrough therapy designation in US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer

  December 9, 2024

   · 

  10 min read
• Press Releases

  Relmada Therapeutics to Discontinue the Reliance II and Relight Phase 3 Studies of REL-1017

  December 9, 2024

   · 

  4 min read